Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J P Leonard

Showing results (81-90 of 98) with videos related to

Pageof 10
Sort By:
European Journal of Immunology|February 17, 1998
Immunoregulation by interleukin-12 in MB49.1 tumor-bearing mice: cellular and cytokine-mediated effector mechanismsS E Hunter, K E Waldburger, D K Thibodeaux, et al.
Annals of the New York Academy of Sciences|January 1, 1989
Expression of mRNA encoding voltage-dependent Ca channels in Xenopus oocytes. Review and progress reportH A Lester, T P Snutch, J P Leonard, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 17, 1996
Thrombopoietic potential and serial repopulating ability of murine hematopoietic stem cells constitutively expressing interleukin 11R G Hawley, T S Hawley, A Z Fong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2012
Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsivenessM S Czuczman, J P Leonard, S Jung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2018
Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsivenessM S Czuczman, J P Leonard, S Jung, et al.
Critical Reviews in Immunology|January 1, 1997
Regulation of the inflammatory response in animal models of multiple sclerosis by interleukin-12J P Leonard, K E Waldburger, R G Schaub, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2010
Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivorsC A Thompson, M E Charlson, E Schenkein, et al.
Leukemia|November 26, 2013
BTK inhibition targets in vivo CLL proliferation through its effects on B-cell receptor signaling activityS Cheng, J Ma, A Guo, et al.
Leukemia|July 4, 2008
Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinibC Yang, P Lu, F Y Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 24, 1999
Autocrine regulation of IL-12 receptor expression is independent of secondary IFN-gamma secretion and not restricted to T and NK cellsD K Thibodeaux, S E Hunter, K E Waldburger, et al.
Pageof 10

Showing results (81-90 of 98) with videos related to

Sort By:
Pageof 10
European Journal of Immunology|February 17, 1998
Immunoregulation by interleukin-12 in MB49.1 tumor-bearing mice: cellular and cytokine-mediated effector mechanismsS E Hunter, K E Waldburger, D K Thibodeaux, et al.
Annals of the New York Academy of Sciences|January 1, 1989
Expression of mRNA encoding voltage-dependent Ca channels in Xenopus oocytes. Review and progress reportH A Lester, T P Snutch, J P Leonard, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 17, 1996
Thrombopoietic potential and serial repopulating ability of murine hematopoietic stem cells constitutively expressing interleukin 11R G Hawley, T S Hawley, A Z Fong, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 24, 2012
Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsivenessM S Czuczman, J P Leonard, S Jung, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 2, 2018
Phase II trial of galiximab (anti-CD80 monoclonal antibody) plus rituximab (CALGB 50402): Follicular Lymphoma International Prognostic Index (FLIPI) score is predictive of upfront immunotherapy responsivenessM S Czuczman, J P Leonard, S Jung, et al.
Critical Reviews in Immunology|January 1, 1997
Regulation of the inflammatory response in animal models of multiple sclerosis by interleukin-12J P Leonard, K E Waldburger, R G Schaub, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2010
Surveillance CT scans are a source of anxiety and fear of recurrence in long-term lymphoma survivorsC A Thompson, M E Charlson, E Schenkein, et al.
Leukemia|November 26, 2013
BTK inhibition targets in vivo CLL proliferation through its effects on B-cell receptor signaling activityS Cheng, J Ma, A Guo, et al.
Leukemia|July 4, 2008
Tyrosine kinase inhibition in diffuse large B-cell lymphoma: molecular basis for antitumor activity and drug resistance of dasatinibC Yang, P Lu, F Y Lee, et al.
Journal of Immunology (Baltimore, Md. : 1950)|November 24, 1999
Autocrine regulation of IL-12 receptor expression is independent of secondary IFN-gamma secretion and not restricted to T and NK cellsD K Thibodeaux, S E Hunter, K E Waldburger, et al.
Pageof 10